LY6E antibody (AA 21-101) (HRP)
Quick Overview for LY6E antibody (AA 21-101) (HRP) (ABIN8006806)
Target
See all LY6E AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 21-101
-
Purpose
- Anti-LY6E/SCA-2 Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human LY6E/SCA-2 recombinant protein (Position: L21-S101).
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- LY6E (Lymphocyte Antigen 6 Complex, Locus E (LY6E))
-
Alternative Name
- LY6E
-
Background
-
Background: Lymphocyte antigen 6E is a protein that in humans is encoded by the LY6E gene. Increased expression of Ly6E is associated with poor survival outcome in multiple malignancies as determined by a survey of more than 130 published clinical studies of gene expression studies on cancer tissue samples and adjacent normal tissues. Ly6E is associated with drug resistance and tumor immune escape in breast cancer. Further research is required to validate Ly6E for translation research.
Gene Full Name: lymphocyte antigen 6 family member E
-
Gene ID
- 4061
-
UniProt
- Q16553
-
Pathways
- Hormone Transport
Target
-